S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
AMD   31.36 (-0.48%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
AMD   31.36 (-0.48%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
DIS   131.13 (-0.96%)
Log in

Chemours Stock Price, News & Analysis (NYSE:CC)

$16.80
+0.73 (+4.54 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
$16.18
Now: $16.80
$17.53
50-Day Range
$13.13
MA: $14.92
$17.00
52-Week Range
$11.71
Now: $16.80
$41.60
Volume337,142 shs
Average Volume2.31 million shs
Market Capitalization$2.75 billion
P/E Ratio2.96
Dividend Yield6.36%
Beta2.57
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
Phone302-773-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.64 billion
Cash Flow$8.32 per share
Book Value$5.96 per share

Profitability

Net Income$995 million

Miscellaneous

Employees7,000
Market Cap$2.75 billion
Next Earnings Date11/4/2019 (Confirmed)
OptionableOptionable

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.


Chemours (NYSE:CC) Frequently Asked Questions

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Wednesday, July 31st. Stockholders of record on Friday, August 16th will be paid a dividend of $0.25 per share on Monday, September 16th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.95%. The ex-dividend date of this dividend is Thursday, August 15th. View Chemours' Dividend History.

How will Chemours' stock buyback program work?

Chemours announced that its board has approved a share repurchase plan on Monday, December 4th 2017, which authorizes the company to buyback $500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company's board believes its stock is undervalued.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) released its quarterly earnings data on Thursday, August, 1st. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.90 by $0.18. The specialty chemicals company earned $1.41 billion during the quarter, compared to analyst estimates of $1.53 billion. Chemours had a return on equity of 71.90% and a net margin of 10.33%. The firm's revenue was down 22.5% compared to the same quarter last year. During the same period in the previous year, the company earned $1.71 EPS. View Chemours' Earnings History.

When is Chemours' next earnings date?

Chemours is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Chemours.

How can I listen to Chemours' earnings call?

Chemours will be holding an earnings conference call on Monday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Chemours issued on next quarter's earnings?

Chemours updated its FY19 earnings guidance on Thursday, August, 1st. The company provided earnings per share (EPS) guidance of $2.37-3.08 for the period, compared to the Thomson Reuters consensus estimate of $3.88.

What price target have analysts set for CC?

12 analysts have issued 1-year price objectives for Chemours' shares. Their forecasts range from $14.50 to $52.00. On average, they anticipate Chemours' stock price to reach $29.77 in the next twelve months. This suggests a possible upside of 77.2% from the stock's current price. View Analyst Price Targets for Chemours.

What is the consensus analysts' recommendation for Chemours?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 7 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Chemours.

Has Chemours been receiving favorable news coverage?

News headlines about CC stock have trended somewhat positive on Wednesday, InfoTrie reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Chemours earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned news coverage about the specialty chemicals company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Chemours.

Are investors shorting Chemours?

Chemours saw a increase in short interest in September. As of September 30th, there was short interest totalling 12,560,000 shares, an increase of 14.5% from the August 30th total of 10,970,000 shares. Based on an average daily trading volume, of 3,460,000 shares, the days-to-cover ratio is presently 3.6 days. Currently, 7.8% of the shares of the company are short sold. View Chemours' Current Options Chain.

Who are some of Chemours' key competitors?

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include E I Du Pont De Nemours And Co (DD), Micron Technology (MU), NVIDIA (NVDA), DowDuPont (DWDP), Alibaba Group (BABA), AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Intel (INTC) and Pfizer (PFE).

Who are Chemours' key executives?

Chemours' management team includes the folowing people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)

Who are Chemours' major shareholders?

Chemours' stock is owned by many different of institutional and retail investors. Top institutional investors include DNB Asset Management AS (0.39%), Selz Capital LLC (0.34%), Alberta Investment Management Corp (0.30%), Rhumbline Advisers (0.26%), Envestnet Asset Management Inc. (0.10%) and State of New Jersey Common Pension Fund D (0.07%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher. View Institutional Ownership Trends for Chemours.

Which institutional investors are selling Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Selz Capital LLC, Zurcher Kantonalbank Zurich Cantonalbank , Nisa Investment Advisors LLC, Brookstone Capital Management, Rhumbline Advisers, Lau Associates LLC and Envestnet Asset Management Inc.. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Mark Newman and Paul Kirsch. View Insider Buying and Selling for Chemours.

Which institutional investors are buying Chemours stock?

CC stock was bought by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, State of New Jersey Common Pension Fund D, DNB Asset Management AS, Investors Research Corp, Pacer Advisors Inc., Proffitt & Goodson Inc., AI Financial Services LLC and Rothschild Investment Corp IL. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown and Susan M Kelliher. View Insider Buying and Selling for Chemours.

How do I buy shares of Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $16.80.

How big of a company is Chemours?

Chemours has a market capitalization of $2.75 billion and generates $6.64 billion in revenue each year. The specialty chemicals company earns $995 million in net income (profit) each year or $5.67 on an earnings per share basis. Chemours employs 7,000 workers across the globe.View Additional Information About Chemours.

What is Chemours' official website?

The official website for Chemours is http://www.chemours.com/.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]


MarketBeat Community Rating for Chemours (NYSE CC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  451 (Thanks for Voting!)
Underperform Votes:  502 (Thanks for Voting!)
Total Votes:  953
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Featured Article: What is Liquidity?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel